Scholarly article on 4-bromo-3-oxo-2-o-tolylhydrazono-butyric acid ethyl ester 26502-52-3 from Journal of the Chemical Society C: Organic p. 656

DOI: 10.1039/j39700000656

Source and publish data:

Journal of the Chemical Society C: Organic p. 656 (1970)

Update date:2022-08-03

Topics:

Authors:

Garg Garg

Singh Singh

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1039/j39700000656

Full text of DOI:10.1039/j39700000656

View Article Online / Journal Homepage / Table of Contents for this issue

View Article Online

Products guided by the article

Product name:4-bromo-3-oxo-2-o-tolylhydrazono-butyric acid ethyl ester

Cas No:26502-52-3

R&D Labs maybe for 26502-52-3

HEZE KINGVOLT CHEMICAL CO., LTD

Contact:86-573-82118911

Address:Juancheng Industry Park
wuxi huabin bio-tech Co.,Ltd(expird)

Contact:86-0510-85133006

Address:hubin road NO157
Anhui Hope-Chem Co., Ltd.

Contact:86-551-63540590

Address:No 1388 Furong Rd., Hefei, Anhui, China
SHANGHAI ARCADIA BIOTECHNOLOGY LTD.

Contact:+86-21-61353236

Address:SUITE 901, BUILDING WENSLI, 1378 LU JIA BANG RD, SHANGAHI 200011, P.R.CHINA
Shanghai agrotree chemical co.,ltd.

Contact:+86-21-50117563

Address:Room 8A,liangfeng building,No.8 dongfang RD.pudong,shanghai,China

Relevant to this article

Reactivity of cyclometallated semicarbazone complexes of Pd(II): Crystal and molecular structures of [Pd{C₆H₄C(Et)=NN(H)C(=O)NH₂}(PPh ₃)][ClO₄] and [Pd{C₆H₄C(Et)=NN(H)C(=O)NH₂}{(Ph ₂PCH₂CH₂)₂PPh-P,P,P}][Cl]

Doi:10.1016/S0022-328X(99)00629-4
(2000)
Doi:10.1080/00268977000100551
(1970)
Synthesis and pharmacological activity of the metabolites of Pratosartan

Doi:10.1248/cpb.54.782
(2006)
Asymmetric mannich synthesis of β-amino acids with two new stereogenic centers at the α and β positions

Doi:10.1002/anie.199703861
(1997)
Pyridyl and furyl epoxides of more than 99% enantiomeric purities: The use of a phosphazene base

Doi:10.1002/(SICI)1099-0690(200003)2000:6<1077::AID-EJOC1077>3.0.CO;2-4
(2000)
14-O-Heterocyclic-substituted naltrexone derivatives as non-peptide mu opioid receptor selective antagonists: Design, synthesis, and biological studies

Doi:10.1016/j.bmcl.2008.12.093
(2009)

Article Doi

DOI: 10.1039/j39700000656